Clinical Trials Browser

OTHER × Lymphoma, B-Cell × Everolimus × Clear all

NCT01665768 2021-10-26

Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

Phase 2 Completed

56 enrolled 10 charts

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Mantle-Cell